 | • レポートコード：MRC2-11QY03968 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ニューカッスル病治療の競争状況、市場シェア ・世界のニューカッスル病治療市場：種類別市場規模 2015年-2020年（弱毒生ワクチン、不活化ワクチン、複合ワクチン） ・世界のニューカッスル病治療市場：種類別市場規模予測 2021年-2026年（弱毒生ワクチン、不活化ワクチン、複合ワクチン） ・世界のニューカッスル病治療市場：用途別市場規模 2015年-2020年（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他） ・世界のニューカッスル病治療市場：用途別市場規模予測 2021年-2026年（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他） ・北米のニューカッスル病治療市場分析：米国、カナダ ・ヨーロッパのニューカッスル病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのニューカッスル病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のニューカッスル病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのニューカッスル病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Indovax、Zoetis、Eli Lilly、Merck、Ceva ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1).
The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a significant growth over a forecast period due to the increasing initiatives by government to ensure food security and awareness regarding mass vaccination programs that would create sustainable demand for vaccines for national stockpiles. The Europe has also contributed the moderate shares and registered a healthy growth rate to the Newcastle Disease Treatment market followed by North America. The APAC has become the lucrative market for Newcastle Disease Treatment and anticipated to register significant shares over the forecast period due to the increasing research and development activities and government initiatives to invest in veterinary vaccines for both livestock and companion animals. The Latin America and MEA are at a nascent stage to the Newcastle Disease Treatment market and expected to show a moderate growth over a forecast period owing to improve access to healthcare facilities.
Market Analysis and Insights: Global Newcastle Disease Treatment Market
The global Newcastle Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Newcastle Disease Treatment Scope and Market Size
Newcastle Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Newcastle Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Indovax
Zoetis
Eli Lilly
Merck
Ceva
…
Market segment by Type, the product can be split into
Live Attenuated Vaccine
Inactivated Vaccine
Conjugated Vaccine
Market segment by Application, split into
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Retail Pharmacies
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Newcastle Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Newcastle Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Live Attenuated Vaccine
1.4.3 Inactivated Vaccine
1.4.4 Conjugated Vaccine
1.5 Market by Application
1.5.1 Global Newcastle Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Veterinary Research Institutes
1.5.5 Retail Pharmacies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Newcastle Disease Treatment Market Perspective (2015-2026)
2.2 Global Newcastle Disease Treatment Growth Trends by Regions
2.2.1 Newcastle Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Newcastle Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Newcastle Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Newcastle Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Newcastle Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Newcastle Disease Treatment Players by Market Size
3.1.1 Global Top Newcastle Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Newcastle Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Newcastle Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Newcastle Disease Treatment Market Concentration Ratio
3.2.1 Global Newcastle Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Newcastle Disease Treatment Revenue in 2019
3.3 Newcastle Disease Treatment Key Players Head office and Area Served
3.4 Key Players Newcastle Disease Treatment Product Solution and Service
3.5 Date of Enter into Newcastle Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Newcastle Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Newcastle Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Newcastle Disease Treatment Market Size by Application (2015-2020)
5.2 Global Newcastle Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Newcastle Disease Treatment Market Size (2015-2020)
6.2 Newcastle Disease Treatment Key Players in North America (2019-2020)
6.3 North America Newcastle Disease Treatment Market Size by Type (2015-2020)
6.4 North America Newcastle Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Newcastle Disease Treatment Market Size (2015-2020)
7.2 Newcastle Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Newcastle Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Newcastle Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Newcastle Disease Treatment Market Size (2015-2020)
8.2 Newcastle Disease Treatment Key Players in China (2019-2020)
8.3 China Newcastle Disease Treatment Market Size by Type (2015-2020)
8.4 China Newcastle Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Newcastle Disease Treatment Market Size (2015-2020)
9.2 Newcastle Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Newcastle Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Newcastle Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Newcastle Disease Treatment Market Size (2015-2020)
10.2 Newcastle Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Newcastle Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Newcastle Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Newcastle Disease Treatment Market Size (2015-2020)
11.2 Newcastle Disease Treatment Key Players in India (2019-2020)
11.3 India Newcastle Disease Treatment Market Size by Type (2015-2020)
11.4 India Newcastle Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Newcastle Disease Treatment Market Size (2015-2020)
12.2 Newcastle Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Newcastle Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Newcastle Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Indovax
13.1.1 Indovax Company Details
13.1.2 Indovax Business Overview
13.1.3 Indovax Newcastle Disease Treatment Introduction
13.1.4 Indovax Revenue in Newcastle Disease Treatment Business (2015-2020))
13.1.5 Indovax Recent Development
13.2 Zoetis
13.2.1 Zoetis Company Details
13.2.2 Zoetis Business Overview
13.2.3 Zoetis Newcastle Disease Treatment Introduction
13.2.4 Zoetis Revenue in Newcastle Disease Treatment Business (2015-2020)
13.2.5 Zoetis Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Newcastle Disease Treatment Introduction
13.3.4 Eli Lilly Revenue in Newcastle Disease Treatment Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Newcastle Disease Treatment Introduction
13.4.4 Merck Revenue in Newcastle Disease Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Ceva
13.5.1 Ceva Company Details
13.5.2 Ceva Business Overview
13.5.3 Ceva Newcastle Disease Treatment Introduction
13.5.4 Ceva Revenue in Newcastle Disease Treatment Business (2015-2020)
13.5.5 Ceva Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Newcastle Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Newcastle Disease Treatment Revenue
Table 3. Ranking of Global Top Newcastle Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Newcastle Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Live Attenuated Vaccine
Table 6. Key Players of Inactivated Vaccine
Table 7. Key Players of Conjugated Vaccine
Table 8. Global Newcastle Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Newcastle Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Newcastle Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Newcastle Disease Treatment Market Share by Regions (2015-2020)
Table 12. Global Newcastle Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Newcastle Disease Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Newcastle Disease Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Newcastle Disease Treatment Players
Table 19. Global Newcastle Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Newcastle Disease Treatment Market Share by Players (2015-2020)
Table 21. Global Top Newcastle Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newcastle Disease Treatment as of 2019)
Table 22. Global Newcastle Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Newcastle Disease Treatment Product Solution and Service
Table 25. Date of Enter into Newcastle Disease Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Newcastle Disease Treatment Market Size Share by Type (2015-2020)
Table 29. Global Newcastle Disease Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Newcastle Disease Treatment Market Size Share by Application (2015-2020)
Table 31. Global Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Newcastle Disease Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 35. North America Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 37. North America Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 41. Europe Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 43. Europe Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 47. China Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 49. China Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 53. Japan Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 55. Japan Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 59. Southeast Asia Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 65. India Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 67. India Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Newcastle Disease Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Newcastle Disease Treatment Market Share (2019-2020)
Table 71. Central & South America Newcastle Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Newcastle Disease Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Newcastle Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Newcastle Disease Treatment Market Share by Application (2015-2020)
Table 75. Indovax Company Details
Table 76. Indovax Business Overview
Table 77. Indovax Product
Table 78. Indovax Revenue in Newcastle Disease Treatment Business (2015-2020) (Million US$)
Table 79. Indovax Recent Development
Table 80. Zoetis Company Details
Table 81. Zoetis Business Overview
Table 82. Zoetis Product
Table 83. Zoetis Revenue in Newcastle Disease Treatment Business (2015-2020) (Million US$)
Table 84. Zoetis Recent Development
Table 85. Eli Lilly Company Details
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Product
Table 88. Eli Lilly Revenue in Newcastle Disease Treatment Business (2015-2020) (Million US$)
Table 89. Eli Lilly Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Newcastle Disease Treatment Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. Ceva Company Details
Table 96. Ceva Business Overview
Table 97. Ceva Product
Table 98. Ceva Revenue in Newcastle Disease Treatment Business (2015-2020) (Million US$)
Table 99. Ceva Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Newcastle Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Live Attenuated Vaccine Features
Figure 3. Inactivated Vaccine Features
Figure 4. Conjugated Vaccine Features
Figure 5. Global Newcastle Disease Treatment Market Share by Application: 2020 VS 2026
Figure 6. Veterinary Hospitals Case Studies
Figure 7. Veterinary Clinics Case Studies
Figure 8. Veterinary Research Institutes Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Newcastle Disease Treatment Report Years Considered
Figure 12. Global Newcastle Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Newcastle Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Newcastle Disease Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Newcastle Disease Treatment Market Share by Players in 2019
Figure 17. Global Top Newcastle Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newcastle Disease Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Newcastle Disease Treatment Revenue in 2019
Figure 19. North America Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Newcastle Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
獣医クロストリジウムワクチンの世界市場（～2026年） Market Analysis and Insights: Global Veterinary Clostridium Vaccine Market The global Veterinary Clostridium Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Clostridium Vaccine Scope and Market Size …- 獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…
- 牛呼吸器疾患治療の世界市場（～2026年） Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, enviro…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 獣医整形外科治療の世界市場（～2026年） Animals commonly suffer from different orthopedic conditions that result in abnormal movement, instability, lameness, and others. Orthopedic conditions such as hip dysplasia, elbow dysplasia, patella luxation, and others require a surgical procedure for the treatment of the condition. The treatment …